Detalhe da pesquisa
1.
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Cancer Immunol Immunother
; 71(6): 1531-1543, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34661709
2.
Enhancing Antigen Cross-Presentation in Human Monocyte-Derived Dendritic Cells by Recruiting the Intracellular Fc Receptor TRIM21.
J Immunol
; 202(8): 2307-2319, 2019 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30796180
3.
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA).
Int J Gynecol Cancer
; 30(8): 1239-1242, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32591370
4.
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults.
Infect Dis Ther
; 11(5): 1999-2015, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36058990
5.
Dominant-negative NFKBIA mutation promotes IL-1ß production causing hepatic disease with severe immunodeficiency.
J Clin Invest
; 130(11): 5817-5832, 2020 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32750042
6.
Physiological Doses of Red Light Induce IL-4 Release in Cocultures between Human Keratinocytes and Immune Cells.
Photochem Photobiol
; 94(1): 150-157, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28763105